Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.77 |
| ▸ | TP53 | P04637 | 5/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.58 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.58 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.58 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16432620 | 0.90 | DRD2 (0.82) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL20525412 | 0.90 | DRD2 (0.81) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL20525366 | 0.89 | DRD2 (0.80) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL16433117 | 0.87 | DRD2 (0.77) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL16432644 | 0.87 | DRD2 (1.00) | DRD2TP53MAPTMEN1KMT2A | |
| SCHEMBL16430961 | 0.87 | DRD2 (0.77) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL20525370 | 0.86 | DRD2 (0.76) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL20525396 | 0.86 | DRD2 (0.76) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL16431001 | 0.84 | DRD2 (0.73) | DRD2TP53MAPTSMN1; SMN2MEN1 | |
| SCHEMBL20525452 | 0.83 | DRD2 (0.71) | DRD2TP53MAPTSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3027612-B1 | 11-OXO-10,11-DIHYDRODIBENZO[B,F][1,4]THIAZEPINE S-OXIDE DERIVATIVES AND THEIR USE AS DOPAMINE D2 RECEPTOR ANTAGONISTS | US HEALTH (US) | 2018-10-10 | — | — | EP | claimed |
| EP-3027612-A1 | 11-OXO-10,11-DIHYDRODIBENZO[B,F][1,4]THIAZEPINE S-OXIDE DERIVATIVES AND THEIR USE AS DOPAMINE D2 RECEPTOR ANTAGONISTS | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2016-06-08 | — | — | EP | claimed |
| WO-2015017412-A1 | 11-OXO-10,11-DIHYDRODIBENZO[B,F][1,4]THIAZEPINE S-OXIDE DERIVATIVES AND THEIR USE AS DOPAMINE D2 RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2015-02-05 | — | — | WO | claimed |